64 related articles for article (PubMed ID: 9085359)
1. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase.
Sládek T; Gerová M; Znojil V; Devát L
Physiol Res; 1996; 45(4):335-8. PubMed ID: 9085359
[TBL] [Abstract][Full Text] [Related]
2. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
[TBL] [Abstract][Full Text] [Related]
3. Long-term inhibition of NO synthase induces cardiac hypertrophy with a decrease in adrenergic innervation.
Gerová M; Hartmannová B; Dolezel S; Jezek L
Physiol Res; 1996; 45(4):339-44. PubMed ID: 9085360
[TBL] [Abstract][Full Text] [Related]
4. Structural alterations in the heart after long-term L-NAME and D-NAME treatment.
Pechánová O; Bernátová I; Babál P
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():6-9. PubMed ID: 10707823
[TBL] [Abstract][Full Text] [Related]
5. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Bernátová I; Pechánová O; Pelouch V; Simko F
J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
[TBL] [Abstract][Full Text] [Related]
7. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
Bernátová I; Pechánová O; Simko F
Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthesis blockade increases hypertrophy and cardiac fibrosis in rats submitted to aerobic training.
Souza HC; Penteado DM; Martin-Pinge MC; Barbosa Neto O; Teixeira Vde P; Blanco JH; Silva VJ
Arq Bras Cardiol; 2007 Aug; 89(2):88-93, 99-104. PubMed ID: 17874014
[TBL] [Abstract][Full Text] [Related]
9. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues.
Pechánová O; Bernátová I
Physiol Res; 1996; 45(4):305-9. PubMed ID: 9085354
[TBL] [Abstract][Full Text] [Related]
11. Myocardial microcirculation stereological changes in rats subjected to nitric oxide synthesis inhibition.
Pereira LM; Mandarim-De-Lacerda CA
Pathol Res Pract; 1999; 195(3):177-81. PubMed ID: 10220798
[TBL] [Abstract][Full Text] [Related]
12. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies.
Buhimschi IA; Shi SQ; Saade GR; Garfield RE
Am J Obstet Gynecol; 2001 Mar; 184(4):686-93. PubMed ID: 11262473
[TBL] [Abstract][Full Text] [Related]
13. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
Sanada S; Node K; Minamino T; Takashima S; Ogai A; Asanuma H; Ogita H; Liao Y; Asakura M; Kim J; Hori M; Kitakaze M
Hypertension; 2003 Apr; 41(4):963-7. PubMed ID: 12629037
[TBL] [Abstract][Full Text] [Related]
14. Long-term NO synthase inhibition affects heart weight and geometry of coronary and carotid arteries.
Kristek F; Gerová M
Physiol Res; 1996; 45(5):361-7. PubMed ID: 9085363
[TBL] [Abstract][Full Text] [Related]
15. Functional mechanisms of myocardial microcirculation in left ventricular hypertrophy: a hypothetical model of capillary remodeling post myocardial infarction.
Waller C; Hiller KH; Pfaff D; Gattenlöhner S; Ertl G; Bauer WR
Microvasc Res; 2008 Jan; 75(1):104-11. PubMed ID: 17540413
[TBL] [Abstract][Full Text] [Related]
16. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
[TBL] [Abstract][Full Text] [Related]
17. Involvement of nitric oxide synthase in skeletal muscle adaptation to chronic overload.
Smith LW; Smith JD; Criswell DS
J Appl Physiol (1985); 2002 May; 92(5):2005-11. PubMed ID: 11960951
[TBL] [Abstract][Full Text] [Related]
18. Basal, but not overload-induced, myonuclear addition is attenuated by NG-nitro-L-arginine methyl ester (L-NAME) administration.
Gordon SE; Westerkamp CM; Savage KJ; Hickner RC; George SC; Fick CA; McCormick KM
Can J Physiol Pharmacol; 2007 Jun; 85(6):646-51. PubMed ID: 17823627
[TBL] [Abstract][Full Text] [Related]
19. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
[TBL] [Abstract][Full Text] [Related]
20. Remodelling of septal branch of coronary artery and carotid artery in L-NAME treated rats.
Kristek F; Gerová M; Devát L; Varga I
Physiol Res; 1996; 45(4):329-33. PubMed ID: 9085358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
